
CRISPR Reverses Chemo Resistance in Lung Cancer
CRISPR technology reverses chemotherapy resistance in lung cancer by disabling the NRF2 gene. This improves drug sensitivity and slows tumor growth, offering a novel strategy for resistant cancers.

CRISPR technology reverses chemotherapy resistance in lung cancer by disabling the NRF2 gene. This improves drug sensitivity and slows tumor growth, offering a novel strategy for resistant cancers.

Scientists use CRISPR to control memory expression by modifying the epigenetic state of memory cells via Arc gene. This offers new insights into memory storage and potential treatments for memory-related disorders.